Clinical trials
Recruiting Phase 2 Liposarcoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Oslo University Hospital | 2 |
| Fudan University | 1 |
| HRYZ Biotech Co. | 1 |
| Iovance Biotherapeutics, Inc. | 1 |
| Lund University Hospital | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liposarcoma | 7 |
| Sarcoma | 6 |
| Histiocytoma, Malignant Fibrous | 4 |
| Leiomyosarcoma | 4 |
| Sarcoma, Synovial | 3 |
| Dermatofibrosarcoma | 2 |
| Desmoplastic Small Round Cell Tumor | 2 |
| Fibrosarcoma | 2 |
| Hemangiosarcoma | 2 |
| Neurofibrosarcoma | 2 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.